President Biden Calls for Review of US Drug Supply Chain
SPONSORED CONTENT
-
Supply Chain Security -- If Your API Supply Is Important, You Should Take Five Minutes To Read This
- Information
- February 24, 2021
We all know that active pharmaceutical ingredient (API) end user supply chain security is a critical component to getting the finished dosage to market. Securing the supply chain means that... -
Embarking Upon the Commercial Manufacturing Journey for a Biologic: Strategies to Achieve Successful Approval & Launch
- Information
- February 10, 2021
In this Q&A, four Catalent Biologics experts share how scale-up, regulatory expectations, demand forecasting and process validation all play a role in the success of a biologic when embarking upon... -
Build or Buy Challenge: Six Advantages of Using a Pre-Qualified, Fully Customizable GMP Environment
- Information
- January 27, 2021
Today, biopharma companies face growing challenges when capacity is at a premium. Investment decisions must be made to ultimately determine the expansion of facilities, headcounts and technology...
Read all Top Industry News: Click here for Pharma News + Click here for Supplier News.